Article Details

Ianalumab/Ibrutinib Combo Shows Promising Activity in CLL

Retrieved on: 2021-02-26 18:33:45

Tags for this article:

Click the tags to see associated articles and topics

Ianalumab/Ibrutinib Combo Shows Promising Activity in CLL. View article details on hiswai:

Excerpt

VAY736 is an investigational Fc-engineered afucosylated monoclonal antibody that targets the BAFF receptor and enhances natural killer (NK) cell ...

Article found on: www.onclive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo